Hydrolytic Activity of Mitochondrial F 1 F O -ATP Synthase as a Target for Myocardial Ischemia–Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors
Journal of Medicinal Chemistry · 23.11.2023 · 66 (22) · 15115-15140
DOI: 10.1021/acs.jmedchem.3c01048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.11.2023. Verfasst von Panagiota-Efstathia Nikolaou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece. Hauptthemen laut MEDLINE: Myocardial Infarction, Myocardial Reperfusion Injury, Mitochondrial Proton-Translocating ATPases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: British Heart Foundation, European Cooperation in Science and Technology.
Abstract (Originalsprache)
F1FO-ATP synthase is the mitochondrial complex responsible for ATP production. During myocardial ischemia, it reverses its activity, hydrolyzing ATP and leading to energetic deficit and cardiac injury. We aimed to discover novel inhibitors of ATP hydrolysis, accessing the druggability of the target within ischemia(I)/reperfusion(R) injury. New molecular scaffolds were revealed using ligand-based virtual screening methods. Fifty-five compounds were tested on isolated murine heart mitochondria and H9c2 cells for their inhibitory activity. A pyrazolo[3,4-c]pyridine hit structure was identified and optimized in a hit-to-lead process synthesizing nine novel derivatives. Three derivatives significantly inhibited ATP hydrolysis in vitro, while in vivo, they reduced myocardial infarct size (IS). The novel compound 31 was the most effective in reducing IS, validating that inhibition of F1FO-ATP hydrolytic activity can serve as a target for cardioprotection during ischemia. Further examination of signaling pathways revealed that the cardioprotection mechanism is related to the increased ATP content in the ischemic myocardium and increased phosphorylation of PKA and phospholamban, leading to the reduction of apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- Department of Life Sciences, University of Coimbra and Center for Neurosciences and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
- The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, United Kingdom.
- Athena Research and Innovation Center in Information Communication & Knowledge Technologies, 15125 Marousi, Greece.
ORCID-Profile: George Lambrinidis, Dimitrios Karagiannis, Carlos M Palmeira, Emmanuel Mikros
Förderung
- British Heart Foundation
- European Cooperation in Science and Technology
Zitieren
APA
Nikolaou, P. E., Lambrinidis, G., Georgiou, M., Karagiannis, D., Efentakis, P., Bessis-Lazarou, P., Founta, K., Kampoukos, S., Konstantin, V., Palmeira, C. M., Davidson, S. M., Lougiakis, N., Marakos, P., Pouli, N., Mikros, E., & Andreadou, I. (2023). Hydrolytic Activity of Mitochondrial F 1 F O -ATP Synthase as a Target for Myocardial Ischemia–Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors. Journal of Medicinal Chemistry, 66(22), 15115-15140. https://doi.org/10.1021/acs.jmedchem.3c01048
Vancouver
Nikolaou PE, Lambrinidis G, Georgiou M, Karagiannis D, Efentakis P, Bessis-Lazarou P, et al. Hydrolytic Activity of Mitochondrial F 1 F O -ATP Synthase as a Target for Myocardial Ischemia–Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors. Journal of Medicinal Chemistry. 2023;66(22):15115-15140. doi:10.1021/acs.jmedchem.3c01048
BibTeX
@article{Nikolaou2023,
author = {Nikolaou, Panagiota-Efstathia and Lambrinidis, George and Georgiou, Maria and Karagiannis, Dimitrios and Efentakis, Panagiotis and Bessis-Lazarou, Pavlos and Founta, Konstantina and Kampoukos, Stavros and Konstantin, Vasilis and Palmeira, Carlos M and Davidson, Sean M and Lougiakis, Nikolaos and Marakos, Panagiotis and Pouli, Nicole and Mikros, Emmanuel and Andreadou, Ioanna},
title = {Hydrolytic Activity of Mitochondrial F 1 F O -ATP Synthase as a Target for Myocardial Ischemia–Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {22},
pages = {15115--15140},
doi = {10.1021/acs.jmedchem.3c01048}
}
EUVIMED